Search Results
#
Oct 28, 2022, 4:25 PM
Final report of year one.
#
Oct 11, 2022, 4:12 PM
Final update by Dr. Bosnakovski.
#
Aug 4, 2022, 2:34 PM
Dr. Sanchez provides a final update on his novel tongue EIM assessment device.
#
Aug 4, 2022, 1:51 PM
Final udpate from Dr Guo on the generation of a craniofacial muscle model of FSHD from iPSCs.
#
Aug 4, 2022, 12:47 PM
Dr. Ozes provides a brief update on progress in testing quite novel DUX4 inhibitors.
#
Aug 4, 2022, 12:37 PM
Update on MOVE FSHD study.
#
May 13, 2022, 11:54 PM
Final report from Dr. Tapscott on his multi-year grant program.
#
May 8, 2022, 9:06 PM
Dr. Jagannathan provides a final research report.
#
May 5, 2022, 3:59 PM
Final report from Dr. Rajanikanth Vangipurapu.
#
Mar 1, 2022, 11:22 AM
Dr. Hiramuki provides a final project update.
#
Feb 7, 2022, 12:46 PM
Dr. Heher provides an update on his innovative mitochondria-targeted antioxidants research.
#
Jan 25, 2022, 2:26 PM
Dr. Statland provides an 18 month update on the current state of CTRN.
#
Dec 8, 2021, 3:38 PM
Dr. Bosnakovski provides an initial update on his project.
#
Nov 22, 2021, 12:27 PM
Dr. Sanchez provides an update on the initial phase of his clinical trial
#
Nov 20, 2021, 10:55 AM
Dr. Harper provides a final update on grant progress.
#
Nov 20, 2021, 10:22 AM
Dr. Marusak provides an interim update on grant progress.
#
Nov 13, 2021, 12:14 PM
Dr. Bloch provides a final report on progress.
#
Oct 14, 2021, 8:05 PM
Dr. Saad provides a final update on his grant progress.
#
Sep 24, 2021, 4:38 PM
Dr. Ozes provides an update to his successful work in finding a potential small molecule inhibitor for DUX4.
#
Sep 11, 2021, 12:54 PM
Dr. Vangipurapu provides an update on his research.
#
Aug 9, 2021, 12:19 PM
Dr. Jagannathan provides an update on research progress.
#
Jul 15, 2021, 3:57 PM
Dr. Statland provides a second update on the MOVE FSHD Study.
#
Jun 10, 2021, 10:01 AM
Dr. Lek provides a final update to her screening grant.
#
Jun 4, 2021, 10:58 AM
Dr. Tawil provides an update to his multi-year grant.
#
Jun 4, 2021, 10:33 AM
Dr. Tapscott provides an update to his multi-year grant.
#
May 28, 2021, 11:09 AM
Dr. Hamm provides a final report on work performed during her Friends of FSH Research Fellowship.
#
May 25, 2021, 9:45 AM
Dr. Wang provides a final report on the FlexFund grant, which supported multiple clinical trials at the University of Washington.
#
May 18, 2021, 9:14 AM
Dr. Jones provides a final update on the funding provided for low-cost test diagnostic.
#
May 7, 2021, 4:37 PM
Dr. Tawil provides a final progress update.
#
Apr 20, 2021, 7:53 PM
Dr. Afrooz Rashnonejad provides a final update on her project.
#
Apr 18, 2021, 10:57 AM
Dr. Harper provides an update on his project.
#
Apr 18, 2021, 10:06 AM
Darina Šikrová provides a final update on her project.
#
Apr 17, 2021, 4:38 PM
Progress update from Dr. Johnstone regarding termination of the project.
#
Mar 16, 2021, 2:35 PM
Dr. Kyba provides an update on his clinical study reimbursement expenses.
#
Mar 16, 2021, 2:16 PM
Dr. Hamm provides an update on the molecular mechanisms that occur in FSHD.
#
Mar 6, 2021, 9:18 AM
Dr Jagannathan provides an update on her lab's research.
#
Mar 6, 2021, 8:56 AM
Dr. Statland provides an update to the MOVE FSHD study.
#
Feb 1, 2021, 7:53 PM
Dr. Saad provides a 6-month update on his work.
#
Dec 1, 2020, 10:36 AM
Dr. Marusak provides a one-year update on their progress.
#
Nov 21, 2020, 9:52 AM
Dr. Tapscott and provides an update on his multi-year grant.
#
Nov 15, 2020, 11:57 AM
Dr. Šikrová provides an update on grant progress.
#
Oct 25, 2020, 5:09 PM
Dr. Rashnonejad provides an update on a potential therapeutic.
#
Oct 14, 2020, 1:27 PM
Dr. Bloch provides an update on progress investigating a potential biomarker for FSHD.
#
Oct 14, 2020, 11:27 AM
Dr. Wang provides an update on the various studies supported by Friends at the UW.
#
Oct 6, 2020, 11:43 AM
Dr. Lek provides an update on progress establishing a pipeline for testing the therapeutic potential of the drugs to reduce DUX4 toxicity, starting with everolimus.
#
Sep 15, 2020, 9:28 AM
Dr. Peter Jones provides a 6 month update on validating an affordable epigenetic diagnostic. The validation could be helped by more volunteers.
#
Sep 14, 2020, 4:48 PM
Dr. Rabi Tawil provides an update on the expansion of the ReSolve Study to include two European Sites.
#
Sep 10, 2020, 9:27 AM
Dr. Vangipurapu from the Sverdrup Lab provides a progress update.
#
Aug 6, 2020, 7:51 AM
Dr. Jagannathan provides an update on her lab's progress so far on aberrant RNA.
#
Jun 12, 2020, 1:32 PM
Dr. Hamm provides a final update to her Wellstone Fellowship project.
#
Jun 11, 2020, 10:08 AM
Dr. Tawil provides an update on extended genetic testing for current and new patients in the National Registry.
#
May 20, 2020, 3:24 PM
Dr. Tapscott provides an update on his multi-year grant.
#
May 20, 2020, 2:41 PM
Dr. Marusak provides an update on progress so far.
#
Apr 17, 2020, 10:02 AM
Darina Šikrová provides a progress update of her work on using a novel genome editing tool to target DUX4.
#
Mar 10, 2020, 1:46 PM
Latest progress from Yosuke Hiramuki.
#
Jan 28, 2020, 1:31 PM
Rashnonajad provides the initial progress update showing efficiently reduced DUX4 mRNA and consequently DUX4 protein in FSHD cells.
#
Dec 9, 2019, 3:03 PM
Sachiko Homma provides the final update on DUX4's apparent affect on muscle degradation.
#
Nov 25, 2019, 10:32 AM
Wellstone FSHD Fellowship recipient Danielle Hamm provides an update on the first six months of progress.
#
Nov 24, 2019, 7:35 PM
The funding provided by Friends of FSH Research and the Carrino Foundation has supported Dr. Amy Campbell, a dedicated professional highly skilled in FSHD research who oversees the completion of high-impact studies on FSHD and provides scientific and technical oversight for graduate students, postdoctoral fellows, and collaborators seeking to initiate and/or advance projects in FSHD.
#
Nov 4, 2019, 2:21 PM
Dr. Pakula provides her final update on this research project.
#
Oct 24, 2019, 4:35 PM
Yosuke Hiramuki provides an update on his novel mouse model.
#
Oct 24, 2019, 3:41 PM
Darina Šikrová provides a progress update of her work on using a novel genome editing tool to target DUX4.
#
Sep 29, 2019, 6:37 PM
Final progress update.
#
Aug 5, 2019, 10:19 AM
Dr. Tawil provides an update on year three of his project to get genetic testing performed for those in the registry who do not have it, and thus create a larger viable pool for upcoming clinical trials.
#
Aug 2, 2019, 10:18 AM
Travel reports from recipients of travel grants for the 2019 FSH Society International Research Congress.
#
Aug 1, 2019, 5:52 PM
Sujatha Jagannathan provides a brief final summary of work on her research.
#
Aug 1, 2019, 12:24 PM
Yi-Wen Chen provides a final summary of her research activities.
#
Aug 1, 2019, 12:08 PM
Dr. Tawil provides a brief update on the two CTRN European sites funded.
#
Jun 5, 2019, 12:32 PM
Dr. Bloch provides a final update on his xenograft mouse model project.
#
May 29, 2019, 8:16 AM
The funding provided by Friends of FSH Research and the Carrino Foundation has supported Dr. Amy Campbell, a dedicated professional highly skilled in FSHD research who oversees the completion of high-impact studies on FSHD and provides scientific and technical oversight for graduate students, postdoctoral fellows, and collaborators seeking to initiate and/or advance projects in FSHD.
#
Apr 13, 2019, 2:52 PM
Dr. Pakula provides an update on her research.
#
Apr 3, 2019, 2:55 PM
Prof. Dr. Arend Heerschap provides an update on his research to determine in which muscles and where in a muscle DUX4 starts to be harmful.
#
Feb 27, 2019, 11:47 AM
Sachiko Homma provides an update on her investigation into DUX4-induced muscle atrophy.
#
Feb 15, 2019, 11:32 AM
Dr. Kyba's final update on investigating what exactly is happening to muscles as FSHD progresses.
#
Dec 27, 2018, 11:06 AM
Jocelyn Eidahl provides a progress update on the past 6 months of investigating the role of post-translational modification on FSHD protein DUX4.
#
Dec 18, 2018, 8:36 PM
Yi-Wen Chen provides a summary of the first six months of research activities.
#
Dec 3, 2018, 10:07 AM
Amy Campbell provides a brief update of her work overseeing lab personnel, publications, etc.
#
Nov 29, 2018, 4:44 PM
Sujatha Jagannathan provides a brief summary of the first six months of work on her research.
#
Nov 20, 2018, 8:22 AM
Dr. Pakula provides a progress update on characterizing single DUX4 expressing cells.
#
Nov 16, 2018, 9:43 AM
Progress update from Dr. Kyba.
#
Nov 14, 2018, 11:01 AM
Update from Dr. Wang on his clinical study.
#
Nov 5, 2018, 5:19 PM
Dr. Tawil provides a brief update on the two CTRN European sites funded.
#
Jul 31, 2018, 3:31 PM
Charles Emerson provides the final update on his recent study.
#
Jul 17, 2018, 5:51 PM
Jocelyn Eidahl, Post-Doctoral Scientist at Nationwide Children’s Hospital provides a progress update.
#
Jul 11, 2018, 9:34 AM
Yi-Wen Chen DMV PhD provides an update on investigating 3rd generation oligonucleotides.
#
Jul 5, 2018, 11:47 AM
Dr. Tawil provides an update on year two of his project to get genetic testing performed for those in the registry who do not have it, and thus create a larger viable pool for upcoming therapeutic trials.
#
Jan 1, 2018, 9:01 PM
Yi-Wen Chen DMV PhD provides an update on investigating 3rd generation oligonucleotides.
#
Dec 31, 2017, 8:55 PM
Initial progress update provided by Premi Haynes PhD.
#
Dec 15, 2017, 8:44 PM
Jocelyn Eidahl, Post-Doctoral Scientist at Nationwide Children’s Hospital provides a progress update.
#
Dec 14, 2017, 8:40 PM
Final progress update from Dr. Wagner.
#
Nov 15, 2017, 8:09 PM
Dr. Bloch provides a brief update of his progress on a xenograft mouse model.
#
Jun 8, 2017, 6:21 PM
Update from Dr. Wagner regarding her study of the histopathological features of FSHD affected muscle.
#
May 30, 2017, 6:11 PM
Dr. Wang provides a progress update on his clinical study.
#
May 30, 2017, 6:07 PM
Progress update from Dr. Tawil on making the National Registry more useful for research by providing genetic testing.
#
Mar 24, 2017, 3:30 PM
Hideki Aihara PhD provides an update on his research into the structure of the Dux4 homeodomains in complex with DNA.
#
Jan 31, 2017, 1:11 PM
Update from Dr. Maura Parker on optimizing expansion of human muscle stem cells for transplant into mice.
#
Dec 31, 2016, 12:55 PM
Update by Jong Won Lim, postdoctoral fellow.
#
Dec 1, 2016, 11:51 AM
Lay summary for the ENMC Workshop.
#
Nov 14, 2016, 10:40 AM
Final update for grant to Genea Biocells.
#
Mar 24, 2016, 3:27 PM
Dr. Robert Bloch provides an update on his research into xenografting.
#
Feb 4, 2015, 2:06 PM
The Tapscott lab is entering the final year of a four-year grant. Let's see how they are doing.
#
Feb 3, 2015, 9:07 AM
Progress update from Drs. Miller and Tawil.
#
Aug 31, 2014, 2:57 PM
Drs. Filippova and Miller present their final results from the study.
#
Jul 31, 2014, 10:12 PM
Jong Won Lim, postdoctoral fellow, provides an update on his fellowship.
#
Jan 31, 2014, 4:36 PM
Jong-Won Lim progress update.
#
Jan 8, 2014, 9:55 AM
The research goals of 2011-13 were to 1) create a model of FSHD that displayed features of the disease in muscles of laboratory mice through production of human DUX4 protein and 2) to test a therapeutic approach to block production of DUX4 protein in patient cell lines grown in tissue culture dishes in the laboratory.
#
Feb 6, 2013, 9:56 AM
Final progress update from FSH Scholar Barbara Page.
#
Nov 11, 2012, 1:03 PM
Friends of FSH Research has helped fund another ground breaking project that has shed new light on the mechanism of muscle damage in Facioscapulohumeral Muscular Dystrophy, and suggests new targets for treatment.
#
Oct 22, 2012, 12:55 PM
The milestones for year one were to perform an initial screen for Platform 1 and prepare and validate Platform 2.
#
Jul 24, 2012, 12:23 PM
The Miller Lab has made exciting progress in the development of a platform for screening genes and compounds with activities that affect FSHD-specific pathogenic processes.
#
Apr 17, 2012, 11:12 AM
Asymmetric Bidirectional Transcription from the FSHD-Causing D4Z4 Array Modulates DUX4 Production
#
Dec 28, 2011, 9:54 AM
DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy.
#
Nov 20, 2011, 9:16 AM
The gene thought to cause FSHD, Double Homeobox Protein 4 (DUX4), is unusual because it is encoded within each unit (D4Z4) of large arrays present on chromosomes 4 and 10.
#
Jan 16, 2008, 11:27 AM
Miller & Tapscott provide a first year summary of progress.